The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

A new trial involving 17,000 people on weight loss drugs found they reduced the risk of stroke and heart disease by half.

Ozempic is a prescription drug used to deal with conditions related to high blood sugar levels and for diabetes management.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Despite Ozempic being the most recognisable brand name, as far as the people prescribing it are concerned weight loss is ...

Despite being a drug designed to treat diabetes, some celebs have found success using Ozempic for weight loss purposes.

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

The announcement follows new research that suggested drugs like Wegovy, Mounjaro and Ozempic slashed the risk of contracting ...

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health ...